Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Cash from Financing Activities (2019 - 2025)

Volitionrx's Cash from Financing Activities history spans 9 years, with the latest figure at $6.2 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 168.83% year-over-year to $6.2 million; the TTM value through Dec 2025 reached $17.1 million, up 97.44%, while the annual FY2025 figure was $17.1 million, 97.44% up from the prior year.
  • Cash from Financing Activities reached $6.2 million in Q4 2025 per VNRX's latest filing, up from $1.6 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $20.2 million in Q1 2021 to a low of -$460198.0 in Q2 2022.
  • Average Cash from Financing Activities over 5 years is $4.2 million, with a median of $2.2 million recorded in 2021.
  • The largest YoY upside for Cash from Financing Activities was 13203.23% in 2022 against a maximum downside of 191.81% in 2022.
  • A 5-year view of Cash from Financing Activities shows it stood at $2.1 million in 2021, then tumbled by 55.85% to $925964.0 in 2022, then soared by 307.19% to $3.8 million in 2023, then tumbled by 39.27% to $2.3 million in 2024, then skyrocketed by 168.83% to $6.2 million in 2025.
  • Per Business Quant, the three most recent readings for VNRX's Cash from Financing Activities are $6.2 million (Q4 2025), $1.6 million (Q3 2025), and $5.7 million (Q2 2025).